Atlas Trials

Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

Clinical trial NCT01617200 · COMPLETED

Trial details

NCT number
NCT01617200
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-12-01
Primary completion
2015-03-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.